Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy.

about

Nongenetic markers in heart failure.

P2860

Q48065394-0A67192C-290A-4374-B739-564F9DA5235E

P2860

Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy.

Item

http://www.wikidata.org/entity/Q48540226

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Interventricular lead separati ...... iac resynchronization therapy.

@en

Interventricular lead separati ...... iac resynchronization therapy.

@nl

type

Item

label

Interventricular lead separati ...... iac resynchronization therapy.

@en

Interventricular lead separati ...... iac resynchronization therapy.

@nl

prefLabel

Interventricular lead separati ...... iac resynchronization therapy.

@en

Interventricular lead separati ...... iac resynchronization therapy.

@nl

P1476

Interventricular lead separati ...... diac resynchronization therapy

@en

P2093

Athar A Badar

http://www.w3.org/2001/XMLSchema#string

Derek T Connelly

http://www.w3.org/2001/XMLSchema#string

Roy S Gardner

http://www.w3.org/2001/XMLSchema#string

Sheena Templeton

http://www.w3.org/2001/XMLSchema#string

Stephen J Pettit

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Cardiac resynchronization in chronic heart failure.

Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial.

Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation

What is treatment success in cardiac resynchronization therapy?

Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management.

Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.

P304

797-806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.13.159

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ninian N Lang

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25224936

http://www.w3.org/2001/XMLSchema#string

Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy.

about

P2860

P2860

Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698